Effects of new dialysate for Japanese dialysis patients (K5) on serum electrolytes, acid-base balance, and calcium mass balance: A prospective multicenter clinical trial.
Not Applicable
Recruiting
- Conditions
- End-stage kidney disease
- Registration Number
- JPRN-UMIN000043714
- Lead Sponsor
- Shirasagi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with liver dysfunction (serum AST or ALT >= 100 U/L) or cardiac function disorder (>= III of NYHA classification) or respiratory disorder (PO2 < 60 mmHg)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in serum potassium, calcium, magnesium, pH, bicarbonate, and glucose levels for one year
- Secondary Outcome Measures
Name Time Method Calcium mass balance during dialysis